RecruitingNCT07112937

The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study

Sponsor

The Institute of Molecular and Translational Medicine, Czech Republic

Enrollment

150 participants

Start Date

May 2, 2023

Study Type

OBSERVATIONAL

Conditions

Rectal Cancer Patients

Summary

The prospective study will focus on patients undergoing multimodal treatment for rectal cancer. The main objective of the study will be to monitor changes in circulating tumor cells (CTCs) in the peripheral blood of patients during multimodal treatment. For each patient enrolled in the study, peripheral blood samples will be collected at specified time intervals to determine the presence and quantity of CTCs. The CTCs levels will be compared among rectal cancer patients with neoadjuvant chemoradiotherapy and without neoadjuvant chemotherapy.

Eligibility

Min Age: 18 Years

Exclusion Criteria1

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

University Hospital Ostrava

Ostrava, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07112937

Related Trials

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

NCT066476801 location

Selective Total Mesorectal Excision Based on Intra-Operative Frozen Section From Local Excision in Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

NCT073378111 location